CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia

Neurological Sciences

Volumn 33, Issue 5, 2012, Pages 973-977

  De Rino, Francesca ^a   Martinelli Boneschi, Filippo ^b,c   Caso, Francesca ^b   Zuffi, Marta ^a   Zabeo, Matteo ^a   Passerini, Gabriella ^d   Comi, Giancarlo ^b,c   Magnani, Giuseppe ^b,c   Franceschi, Massimo ^a  

^a IRCCS MULTIMEDICA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c Neurological Unit   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; Beta amyloid; CSF; Frontotemporal dementia; Phospho tau; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; METABOLITE; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; ROC CURVE; TAU PROTEINS;

EID: 84869235262     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0866-z     Document Type: Article

References (28)

1. Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA (2004) The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 58:1615-1621
2. Stopford CL, Snowden JS, Thompson JC, Neary D (2008) Variability in cognitive presentation of Alzheimer's disease. Cortex 43:185-195 (Pubitemid 351729233)
3. Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51:1546-1554
4. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944 (Pubitemid 14076461)
5. Thompson JC, Stopford CL, Snowden JS, Neary D (2005) Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 76:920-927 (Pubitemid 40909548)
6. Liscic RM, Storandt M, Cairns NJ, Morris JC (2007) Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. Arch Neurol 64:535-540 (Pubitemid 46588342)
7. Kertesz A, Davidson W, Mc Cabe P, Munoz D (2003) Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord 17:223-229 (Pubitemid 37517790)
8. Rabinovici GD, Seeley WW, Kim EJ et al (2008) Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimer's Dis Other Dement 202(6):474-488 (Pubitemid 351176920)
9. Foster NL, Heidebrink JL, Clark CM et al (2007) PET-FDG improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130:2616-2635 (Pubitemid 47511706)
10. Mendez MF, Shapira JS, Mc Murtray A, Licht E, Miller BL (2007) Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol 64:830-835 (Pubitemid 46919837)
11. Tapiola T, Alafuzoff I, Herukka SK et al (2009) CSF b-amiloid 42 and Tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66:382-389
12. Waldemar G, Dubois B, Emre M et al (2007) Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guidelines. Eur J Neurol 14:e1-e26 (Pubitemid 46088015)
13. Schoonenboom NSM, Pijnenburg YAL et al (2004) Amyloid b 1-42 and phosphorilated tau in CSF as markers for early onset Alzheimer disease. Neurology 62:1580-1584 (Pubitemid 38608199)
14. Kaneramu K, Kameda N, Yamanouchi H (2002) Decreased CSF amyloid b 42 and normal tau levels in dementia with Lewy bodies. Neurology 54:1875-1876
15. Nagga K, Gottfries J, Blennow K, Marcusson J (2002) CSF phospho-tau, total tau and b-amyloid 1-42 in the differentiation between Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 14:183-190 (Pubitemid 36151485)
16. Pennington C, Chohan G, Mackenzie J, Andrews M, Will R, Knight R, Green A (2009) The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease. Neurosci Lett 455(1):56-59
17. Hulstaert F, Blennow K, Ivanoiu A et al (1999) Improved discrimination of AD patients with bA 1-42 and t levels in CSF. Neurology 52:1555-1562 (Pubitemid 29220627)
18. Riemenschneider M, Lautenschlager N, Wagenspfeil S, Diehl J, Drzezga A, Kurz A (2002) Cerebrospinal fluid t and bA 42 proteins identify Alzheimer's disease in subjects with mild cognitive impairment. Arch Neurol 59:1729-1734 (Pubitemid 35340483)
19. Shaw LM, Vanderstichele H, Knapik-Czajka M et al (2009) Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann Neurol 65:403-413
20. Visser PJ, Verhej F, Knol DL et al (2009) Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study. Lancet Neurol 8:619-627
21. Engelborghs S, De Vreese K, Van De Casteele T et al (2008) Diagnostic performance of a CSF-biomarker panel in autopsy confirmed dementia. Neurobiol Aging 29:1143-1159 (Pubitemid 351822410)
22. Bian H, van Swieten JC, Leight S et al (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70:1827-1835 (Pubitemid 351653951)
23. Grossman M, Farmer J, Leight S et al (2005) Cerebral fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol 57:721-729 (Pubitemid 40628861)
24. Kapaki E, Paraskevas GP, Parageorgiou SG et al (2008) Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration. Alzheimer Dis Ass Disord 22:47-53 (Pubitemid 351651397)
25. Cruz De Souza L, Lamari F, Belliard S et al (2011) Cerebrospinal fluid biomarkers in the differential diagnosi of Alzheimer's disease from other cortical dementias. J Neurol Neurosurg Psychiatry 82:240-246
26. Forman MS, Farmer J, Johnson JK et al (2006) Frontotemporal dementia: Clinicopathological correlations. Ann Neurol 59:952-962 (Pubitemid 43830927)
27. Pijnenburg YAL, Schoonenbom NSM, Rosso SM et al (2004) CSF tau and Ab42 are not useful in the diagnosis of frontotemporal lobe degeneration. Neurology 62:1649 (Pubitemid 38608224)
28. Snowden JS, Thompson JC, Stopford CL et al (2011) The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinico-pathological relationships. Brain 134(9):2493-2501